HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabriella Kalna Selected Research

Therapeutics

12/2019CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.
11/2015LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gabriella Kalna Research Topics

Disease

2Neoplasms (Cancer)
12/2019 - 11/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2019

Drug/Important Bio-Agent (IBA)

1perlecanIBA
12/2019
1Lim KinasesIBA
11/2015
1Drug CombinationsIBA
11/2015

Therapy/Procedure

2Therapeutics
12/2019 - 11/2015
1Drug Therapy (Chemotherapy)
12/2019